• 1
    Mannheimer C, Camici P, Chester MR et al. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the treatment of refractory angina. Eur Heart J 2002; 23: 35570.
  • 2
    Mukherjee D, Bhatt D, Roe MT et al. Direct myocardial revascularisation and angiogenesis: how many patients might be eligible? Am J Cardiol 1999; 84: 598600.
  • 3
    Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002; 106: 123742.
  • 4
    Suresh K, Simandi S, Lawson W et al. Maximizing the hemodynamic benefit of enhanced external counterpulsation. Clin Cardiol 1998; 21: 64953.
  • 5
    Taguchi I, Ogawa K, Oida A, Abe S, Kaneko N, Sakio H. Comparison of haemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 2000; 86: 113941.
  • 6
    Arora RR, Chou TM, Jain D et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischaemia and anginal episodes. J Am Coll Cardiol 1999; 33: 183340.
  • 7
    Barsness G, Feldman AM, Holmes DR, Jr, Holubkov R, Kelsey SF, Kennard ED. The International EECP Patient Registry (IEPR). Clin Cardiol 2001; 24: 43542.
  • 8
    Rigby AS. Statistical methods in epidemiology. III. The odds ratio as an approximation to the relative risk. Disabil Rehabil 1999; 21: 14551.
  • 9
    Arora RR, Chou T, Jain D et al. Results of the Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): clinical benefits are sustained at a mean follow-up time of 1-year. J Am Coll Cardiol 1998; 31 (Suppl. A): 214A (abstract 859-2).
  • 10
    Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 2000; 94: 315.
  • 11
    Lawson WE, Hui JCK, Kennard ED, Holudkov R, Kelsey SF. Are the initial benefits of enhanced external counterpulsation sustained at one year?. J Am Coll Cardiol 2001; 37(2 Suppl A): 328A (abstract 1117-75).
  • 12
    Stys TP, Lawson WE, Hui JCK et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002; 89: 82224.
  • 13
    Michaels AD, Linnemeier G, Soran O, Kelsey SF, Kennard ED. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from International EECP Patient Registry [IEPR]). Am J Cariol 2004; 93: 4614.
  • 14
    Lawson WE, Hui JCK, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol 2000; 23: 2548.
  • 15
    Lawson WE, Hui JCK, Zheng ZS et al. Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology 1996; 87: 2715.
  • 16
    Bagger JP, Hall RJC, Koutroulis G, Nihoyannopoulos P. Effects of enhanced external counterpulsation on dobutamine-stress left ventricular wall motion abnormalities in severe chronic angina pectoris. J Am Cardiol 2004; 93: 4657.
  • 17
    Masuda D, Nohara R, Hirai T et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in the patients with chronic stable angina. Eur Heart J 2001; 22: 14518.
  • 18
    Urano H, Ikeda H, Takafumi U, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischaemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001; 37: 939.
  • 19
    Bonetti PO, Barsness GW, Keelan PC et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 17617.
  • 20
    Shechter M, Matetzky S, Feinberg MS, Chouraqui P, Rotstein Z, Hod H. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol 2003; 42: 20905.
  • 21
    Lawson WE, Hui JCK, Lu L, Zheng ZS, Zhang MQ. Benefit effects of EECP on the renin-angiotensin system in patients with coronary artery disease. Eur Heart J 2001; 22: 538 (abstract P2903).
  • 22
    Wu GF, Qiang SZ, Zheng ZS, Zhang MQ, Lawson WE, Hui JCK. A neurohormonal mechanism for the effectiveness of enhanced external counterpulsation. Circulation 1999; 100: I-832 (abstract 4390).
  • 23
    Huang W, Chen Y, Zheng Z, Ahong WF. External counterpulsation increases capillary density during experimental myocardial infarction. Eur Heart J 1999; 20 (Abstr. Suppl.): 168 (abstract P1016).
  • 24
    Masuda D, Fujita M, Nohara R, Matsumori A, Sasayama S. Improvement of oxygen metabolism in iscahemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina. Heart Vessel 2004; 19: 5962.
  • 25
    Ma H, Zheng ZS, Zhang MQ et al. The first affiliated hospital of Sun Yat-Sen University of Medical Science. The safety and efficacy of enhanced external counterpulsation as therapy for unstable angina. Circulation 2000; 102 (Suppl. 2): II-615 (abstract 2982).
  • 26
    Holubkov R, Kennard ED, Foris JM et al. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. Am J Cardiol 2002; 89: 11826.
  • 27
    Lawson WE, Hui JCK, Kennard ED, Barsness G, Kelsey SF, for the IEPR Investigators. Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders. Cardiology 2005; 103: 2016.
  • 28
    Cleland JGF, Coletta AP, Freemantle N, Velavan P, Tin L, Clark L. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the Remission of Heart Failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail 2005; 7: 9316.
  • 29
    Arora RR, Orlando J, Malone A, Bejjanki R, Carlucci M, Kennard L. Safety and efficacy of enhanced external counterpulsation in hypertensive patients with refractory angina pectoris: short- and long-term follow-up. J Am Coll Cardiol 2002; 39 (Suppl. A): 225A (abstract 1154-80).
  • 30
    Lawson WE, Hui JCK, Barness GW, Kennard ED, Kelsey SF, for the IEPR Investigators. Effectiveness of enhanced external counterpulsation in left main patients with angina. Clin Cardiol 2004; 27: 45963.
  • 31
    Lawson WE, Hui JCK, Zheng ZS et al. Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995; 75: 8401.
  • 32
    Loh PH, Windram J, Louis A et al. The immediate and two-year outcomes of enhanced external counterpulsation (EECP) in the treatment of chronic refractory angina – a United Kingdom (UK) perspective. Heart 2005; 91 (Suppl. 1): 223.
  • 33
    Soran O, Kennard ED, Linnemeier G, Kelsey SF. Comparison of clinical outcomes, event free survival and repeat enhanced external counterpulsation (EECP) rates for European and US coronary artery disease patients treated with EECP for angina. Eur Heart J 2003; 24S: 294.